DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
(30/05/2003)
Detail
Radiolabeled peptides in diagnosis and tumor imaging: clinical overview.
(30/05/2003)
Detail
Small non-functioning endocrine tumor of pancreas: comparison with solid cystic tumor.
(30/05/2003)
Detail
Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).
(30/05/2003)
Detail
Therapeutic potential of octreotide in the treatment of liver metastases.
(30/05/2003)
Detail
Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo.
(30/05/2003)
Detail
Differential expression of somatostatin receptors in ependymoma: implications for diagnosis.
(30/05/2003)
Detail
Early changes in islet hormone secretion in the hamster pancreatic cancer model.
(30/05/2003)
Detail
Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.
(30/05/2003)
Detail
Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1.
(30/05/2003)
Detail
Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type.
(30/05/2003)
Detail
Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.
(30/05/2003)
Detail
Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group.
(30/05/2003)
Detail
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.
(30/05/2003)
Detail
Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector.
(30/05/2003)
Detail